The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers
- PMID: 39364250
- PMCID: PMC11447355
- DOI: 10.1016/j.heliyon.2024.e38165
The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers
Abstract
The poly (lactic-co-glycolic acid) (PLGA) based nanoparticles have been applied for drug delivery due to their simple preparation, biodegradability, and ideal biocompatibility. In this study, the factors affecting the degradation of PLGA-based nanoparticles are reviewed, encompassing the ratio of PLA to PGA, relative molecular weight, crystallinity, and preparation process of PLGA nanoparticles. The drug release behavior of PLGA-based nanoparticles, such as the degradation environment, encapsulated drug properties of polymers, and drug loading rates, are also discussed. Since gastrointestinal cancer is one of the major global threats to human health, this paper comprehensively summarizes the application of PLGA nanoparticles in gastrointestinal cancers from diagnosis, chemotherapy, radiotherapy, and novel tumor treatment methods (immunotherapy, gene therapy, and photothermal therapy). Finally, the future application of PLGA-based drug delivery systems in treating gastrointestinal cancers is discussed. The bottleneck of application status and the prospect of PLGA-nanoparticles in gastrointestinal tumor application are presented. To truly realize the great and wide application of PLGA-based nanoparticles, collaborative progress in the field of nanomaterials and life sciences is needed.
Keywords: Chemotherapy; Drug release; Encapsulation; Gastrointestinal cancer; PLGA nanoparticles.
© 2024 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Limeng Yang reports financial support was provided by Xi'an Polytechnic University. Limeng Yang reports a relationship with Xi'an Polytechnic University that includes: employment. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures




Similar articles
-
Mechanistic Analysis of Temperature-Dependent Curcumin Release from Poly(lactic-co-glycolic acid)/Poly(lactic acid) Polymer Nanoparticles.Mol Pharm. 2024 Mar 4;21(3):1424-1435. doi: 10.1021/acs.molpharmaceut.3c01066. Epub 2024 Feb 7. Mol Pharm. 2024. PMID: 38324797
-
Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).Int J Nanomedicine. 2013;8:4315-26. doi: 10.2147/IJN.S51629. Epub 2013 Nov 7. Int J Nanomedicine. 2013. PMID: 24235829 Free PMC article.
-
Impact of PEGylation on an antibody-loaded nanoparticle-based drug delivery system for the treatment of inflammatory bowel disease.Acta Biomater. 2022 Mar 1;140:561-572. doi: 10.1016/j.actbio.2021.12.015. Epub 2021 Dec 16. Acta Biomater. 2022. PMID: 34923097
-
A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems.Pharm Nanotechnol. 2021;9(1):36-50. doi: 10.2174/2211738508666201214103010. Pharm Nanotechnol. 2021. PMID: 33319695 Review.
-
Recent advances of PLGA micro/nanoparticles for the delivery of biomacromolecular therapeutics.Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:1041-1060. doi: 10.1016/j.msec.2017.12.036. Epub 2018 Jan 5. Mater Sci Eng C Mater Biol Appl. 2018. PMID: 30184728 Review.
Cited by
-
Polymers for the treatment of Alzheimer's disease.Front Pharmacol. 2025 Jan 29;16:1512941. doi: 10.3389/fphar.2025.1512941. eCollection 2025. Front Pharmacol. 2025. PMID: 39944627 Free PMC article. Review.
-
Maytansinoids in cancer therapy: advancements in antibody-drug conjugates and nanotechnology-enhanced drug delivery systems.Discov Oncol. 2025 Jan 21;16(1):73. doi: 10.1007/s12672-025-01820-z. Discov Oncol. 2025. PMID: 39838217 Free PMC article. Review.
-
Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases.J Funct Biomater. 2025 Jan 14;16(1):24. doi: 10.3390/jfb16010024. J Funct Biomater. 2025. PMID: 39852580 Free PMC article. Review.
-
Plant extracts with antioxidant and hepatoprotective benefits for liver health: A bibliometric analysis of drug delivery systems.World J Gastroenterol. 2025 May 14;31(18):105836. doi: 10.3748/wjg.v31.i18.105836. World J Gastroenterol. 2025. PMID: 40496363 Free PMC article.
-
The role of non-coding RNAs in the regulation of cell death pathways in melanoma.Discov Oncol. 2025 Jun 11;16(1):1063. doi: 10.1007/s12672-025-02888-3. Discov Oncol. 2025. PMID: 40500552 Free PMC article. Review.
References
-
- Khalili M., Zhou H., Thadi A., Daniels L., Fan Z., Morano W.F., Ang J., Goldstein E., Polyak B., Mapow B.C., Cheng H., Bowne W.B. Slippery nanoparticles as a diffusion platform for mucin producing gastrointestinal tumors. Ann. Surg Oncol. 2020;27:76–84. doi: 10.1245/s10434-019-07493-7. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources